Skip to main content
. 2019 Jan 28;18:5. doi: 10.1186/s12941-019-0304-2

Table 5.

Antibiotic and antiparasitic prescriptions at the referral hospital and health facilities according to laboratory findings

bBSI (n = 65)
n/N (%)
bGII (n = 65)
n/N (%)
pGII (n = 215)
n/N (%)
vGII (n = 29)
n/N (%)
UTI (n = 11)
n/N (%)
CBPN (n = 153)
n/N (%)
No infectiona (n = 269)
n/N (%)
Referral hospital 40/65 (61.54%) 14/65 (21.54) 40/215 (18.60) 6/29 (20.69) 3/11 (27.27) 41/153 (26.80) 86/269 (31.97)
 Antimalarial 31/40 (77.5) 8/14 (57.14) 29/40 (72.5) 3/6 (50) 3/3 (100) 21/41 (51.21) 30/86 (34.88)
 Antibiotic 30/40 (75) 9/14 (64.28) 29/40 (72.5) 6/6 (100) 3/3 (100) 33/41 (80.48) 74/86 (86.04)
 Antiparasitic 0/40 (0) 0/14 (0) 1/40 (2.50) 1/6 (16.67) 0/3 (0) 1/41 (2.43) 2/86 (2.32)
Health facilities 25/65 (38.46) 51/56 (78.46) 175/215 (81.40) 23/29 (79.31) 8/11 (72.73) 112/153 (73.20) 183/269 (68.02)
 Antimalarial 16/25 (64) 39/51 (76.47) 129/175 (73.71) 13/23 (56.52) 7/8 (87.5) 85/112 (75.89) 86/183 (46.99)
 Antibiotic 25/25 (100) 41/51 (80.39) 141/175 (80.57) 20/23 (86.95) 8/8 (100) 97/112 (86.60) 172/183 (93.98)
 Antiparasitic 5/25 (20.00) 16/51 (31.37) 30/175 (17.14) 4/23 (17.39) 1/8 (12.5) 20/112 (17.85) 47/183 (25.68)

bBSI bacterial bloodstream infection, bGII bacterial gastro-intestinal infection, vGII viral gastro-intestinal infection, UTI urinary tract infection, CBPN common bacteria pathogens of nasopharynx

aIncluding malaria infection